Genmab — Maj 2020
-
not that long ago that Bluebird was the markets favourite, now they are changing their CAR-t deal with BMS to get some cash... https://endpts.com/bluebird-takes-200m-payout-from-bristol-myers-as-covid-19-bla-delays-force-execs-to-bring-out-the-budget-ax/
-
Asco LB deadline var 12/3. Men, Phase III clinical research trials for which the final data are not available by the March 12, 2020, deadline may be granted an exception to submit later. Når data ikke foreligger nu, så tror jeg ikke på Andromeda på Asco.
-
Tak Bulder, går ud fra den var til mig
-
BioNTech SE is expected* to report earnings on 05/12/2020 before market open. The report will be for the fiscal Quarter ending Mar 2020
-
BioNTech webcast i morgen kl. 14 https://edge.media-server.com/mmc/p/eb6fxpp7
-
and on : ADC Therapeutics Cuts Price In Second IPO Attempt http://www.globenewswire.com/fr/news-release/2020/05/11/2030913/0/en/ADC-Therapeutics-Announces-Launch-of-Initial-Public-Offering.html https://seekingalpha.com/article/4346111-adc-therapeutics-cuts-price-in-second-ipo-attempt
-
NBI closing ATH var den 20.07.2015 på 4165,87 (der ligger vi nu). Intraday ATH var samme dag på 4194,87.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind